2017 Executive Sponsors
2017 Associate Sponsors
2017 Technology Sponsors
2017 Soapbox Sponsors
2017 Media Partners
2017 Sponsors / Exhibitors
2017 Executive Sponsors
3M Drug Delivery Systems is a global leader and innovator for inhalation and transdermal drug delivery. Between drug discovery and commercialization, we offer: Innovative and proven technology; Global regulatory expertise; Commercial manufacturing; Broad range of customizable system components and product development services.Our expertise increases your opportunity for success. Visit www.3m.com/dds.
BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD designs, manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products.
BD Medical – Pharmaceutical Systems is the partner of choice for the pharmaceutical industry. With innovative prefillable syringes, self-injection systems, safety systems and needle technologies, we offer an extensive selection of solutions designed to protect, package and deliver drug therapies. Our products reflect more than a century of experience and market knowledge, and our experts provide comprehensive system-based service and full product solutions. For more information, visit us at https://bd.com
2017 Associate Sponsors
Insulet Corporation is an innovative medical device company based in Billerica, Massachusetts. Insulet Corporation designs and manufactures the OmniPod Drug Delivery and Diabetes Management Systems. The OmniPod is an easy-to-use, programmable, body-worn, subcutaneous infusion pump used to treat diabetes and infertility. For more information, visit www.insulet.com.
iO life science, formerly LUNAR Lifesciences, partners with healthcare providers to deliver strategy, design and engineering services for medical system and device development with compliance at the core. By unveiling user needs and key value propositions at the onset, we help clients to innovate in a meaningful way.
Creative expression and design-engineering cross fertilization are central to our product development success. By engaging seasoned worldwide resources, iO life bridges award winning, user centric design with cutting edge technology for first rate product development at considerable value.
This global approach coupled with our proven risk-managed process allows iO life to scale effectively and reduce time to market. Ultimately, we provide patients and providers with solutions that adapt to individual lifestyles and deliver measurable outcomes. Start a project at: iolifescience.com
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, please visit us at www.pfizer.com.
PharmaCircle is a leading provider of global information and analytics on drugs, biologics and combination products in all stages of development. PharmaCircle’s premier database delivers an in depth view into drug development and innovation, examining more than 160,000 pipeline programs and marketed products, and the business portfolios and transactions of nearly 16,000 companies worldwide. PharmaCircle also provides expert analyses on more than 6,000 drug delivery technologies and devices. For more information visit: www.pharmacircle.com
2017 Technology Sponsors
Adare is a global specialty pharmaceutical company focused on developing innovative products that can improve the lives of patients whose treatment needs are not fully addressed by current medications. Over 40 products incorporating Adare taste-masking, customized drug release, and bioavailability enhancement proprietary technologies have been commercialized around the world. Visit www.adarepharma.com
Aprecia, the leader in 3DP pharmaceutical manufacturing, is a technology partner dedicated to taking medicine to its fullest potential through truly novel dosage forms. Aprecia’s ZipDose Technology produces high-dose, rapidly-disintegrating oral dosage forms across multiple therapeutic categories. Visit www.aprecia.com to discover how 3DP manufacturing can optimize your brand and pipeline.
Bespak, a Consort Medical company, is a global leader in the development and manufacture of complex drug delivery devices, including innovative Syrina VapourSoft injectable devices, respiratory, nasal and ocular systems. Bespak’s expertise and capabilities have contributed to the industrialisation of some of the world’s leading medical devices. Visit us at www.bespak.com or contact us: email@example.com
For 20 years, BIOCORP has been developing and producing medical devices for the pharmaceutical industry, enhancing drug reconstitution, packaging and delivery. Recognized for its expertise in device R&D, BIOCORP has incorporated software development capacities to offer connected drug delivery systems in order to meet the evolving needs of patients and improve treatment adherence. Learn more at www.biocorp.fr.
Cambridge Design Partnership is a leading product and technology innovation partner with offices in Cambridge, UK and Palo Alto, USA. We are specialists in drug delivery device design, development, prototype and short-run manufacturing, working for some of the world’s largest companies. Our experts in engineering, human factors and industrial design are able to take combination products through a full design cycle and submission, to enable you to launch a product that is customer focused and commercially effective. Certified to ISO13485/9001. Learn more about us at www.cambridge-design.co.uk
Capsugel – now a Lonza company – designs, develops, and manufactures a wide range of innovative dosage forms for the biopharmaceutical and consumer health and nutrition industries. Our unique combination of science, engineering, formulation and capsule expertise enables our customers to optimize the bioavailability, targeted delivery and overall performance of their biopharmaceutical and consumer health and nutrition products. We partner with more than 4,000 customers in over 100 countries to create novel, high-quality and customized solutions that align with our customers’ evolving needs and benefit patients and consumers. Learn more at www.capsugel.com.
Credence MedSystems is a medical technology company focused on delivering medications safely for the benefit of patients, caregivers and partners. The Companion Safety Syringe System was born from Credence’s philosophy of Innovation Without Change. The Companion offers our pharmaceutical partners a simplified path to commercialization of a best-in-class delivery system by providing passive safety and reuse prevention while using existing primary package components. The Companion is available in luer needle, staked needle and dual chamber reconstitution configurations. In all cases, the user performs the injection, receives end-of-dose cues and then the needle automatically retracts into the syringe, which is disabled. Visit us at www.credencemed.com.
Cristal Therapeutics is a clinical stage company developing nanomedicines for the treatment of cancer and other diseases. The company’s product candidates are based on its proprietary CriPec® polymeric platform, which enables the design of customised nanomedicines. CriPec® -based products have the potential to provide enhanced efficacy and reduced side effect profiles, thus offering improved disease treatment. The lead product, CriPec® docetaxel, is in clinical phase Ib studies for the treatment of solid tumours, while several other products are in preclinical development. Learn more at http://cristaltherapeutics.com.
DALI Medical Devices (“DALI”) was founded in 2003, bringing over 20 years of experience in developing drug delivery devices all the way from concept through commercialization. DALI has developed a family of Flexi-Q next-generation auto-injectors in collaboration with Elcam Medical/E3D. The company is developing an innovative new line of customizable unique solutions: Safe Auto-Needles (SANs), for use with any type of syringes/vials/cartridges – for major pharma, generic and bio-similar companies. Learn more at www.dalimed.com.
DelSiTech is a drug delivery and drug development company that works with its partners to turn their active agents into novel drug products. The company’s technology, Silica Matrix, is a biodegradable, biocompatible controlled/extended release platform for non-oral dosage forms. Silica Matrix is suitable for delivery of small molecules and biologics as well as offering thermostability and abuse deterrent properties. DelSiTech also develops its own supergeneric drug products to address significant unmet medical and commercial needs. 1308 is a 3 month hepatitis B product that will enter Phase I this year. Learn more at www.delsitech.com.
DS Technology is your innovative partner for bringing your creative product rapidly to market. In close cooperation with you we create bespoke superior solutions on the basis of your input and your needs. You benefit from our wealth of experience in pharmaceutical processes, a multitude of manufacturing technologies and a careful selection of the most suitable materials. Our focus is on you, your product and your success. Learn more at http://d-s.technology/en.
Elektrofi is a formulation company working on high-concentration, low-viscosity biologics for subcutaneous injections. Our Elektroject™ platform will enable drug manufacturers to more easily develop breakthrough therapies, dramatically improve the convenience of administration, and improve patient access through affordability. Learn more at www.elektrofi.com.
Enable Injections is a late-stage startup company that has developed a disposable body-worn bolus injector to deliver high viscosity/volume payloads up to 50 ml. The system uses a standard vial, cartridge or syringe container closure, and can automatically mix lyophilized solutions. Founded March 2010, the company has R&D, operations and manufacturing facilities in Cincinnati, Ohio. Visit us at enableinjections.com.
Evonik Industries, a global leader in specialty chemicals, provides drug delivery technologies, API manufacturing, intermediates, ingredients for nutraceuticals, amino acids and derivatives. Drug delivery technologies include formulation development services, solubility enhancement, functional excipients, bioresorbable polymers and GMP manufacturing for oral and parenteral formulations. Advanced delivery technologies for extended-release parenterals are offered for small molecules, peptides, proteins, antibodies, and nucleic acids. Learn more at www.evonik.com.
Exicure is a clinical stage biotechnology company developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatory disorders. Learn more at www.exicuretx.com.
Gerresheimer is a leading global partner to the pharmaceutical and healthcare industry. With our specialty glass and plastic products, we are a highly versatile contract manufacturer of custom drug delivery devices, as well as glass and plastic primary packaging containers. We have worldwide operations in Europe, North America, South America and Asia, employ roughly 10,000 employees and generate approximately $1.5 billion in revenue. Our comprehensive product portfolio includes pharmaceutical packaging, diagnostic and medical technology products and complex, customer-specific products for the safe and simple administration of medicines, such as: insulin pens, inhalers, lancing devices, medical lab test systems, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems. In regards to our drug delivery system and medical device capabilities, we are experts in product design; product and process development; IP management; regulatory affairs; mold flow simulations; mold design; mold making; prototyping; small batch and large scale production in ISO Class 7, 8 and 9 clean rooms; DFM/DFA; manual assembly and full automation; drug handling; micromolding; multi-component injection molding; decorating and much more. Let Gerresheimer help you decrease project risk and increase your product’s speed to market today! Visit us at www.gerresheimer.com
Halozyme focuses on developing and commercializing novel enzymatic therapies that target the tumor microenvironment or facilitate drug delivery. Our proprietary product, the ENHANZE™ drug delivery platform, supports strong, value-driving partnerships with leading pharmaceutical companies including Roche, Shire, Pfizer, Janssen, AbbVie and Lilly. The ENHANZE™ platform has sales in 50+ countries through three product approvals. Learn more at www.halozyme.com.
Infuseon Therapeutics, Inc is developing a suite of medical devices that deliver therapeutics directly to tissue. The company’s first 510(k) approved device is the Cleveland Multiport Catheter™ (CMC) system, which uses convection enhanced drug delivery to administer therapeutics to the brain. Infuseon is completing pilot clinical studies with the CMC to treat glioblastoma and continues to build its drug delivery platform strategic alliances and development of additional delivery platforms. Visit www.infuseontherapeutics.com.
iCeutica’s proprietary SoluMatrix™ Fine Particle Technology creates sub-micron sized drug particles which dissolve rapidly in vivo and can increase oral bioavailability, reduce food effects, and minimize PK variability. Additionally, with superior formulation development capabilities, iCeutica provides our pharmaceutical partners with a cost-effective and reliable pathway to success. Learn more at www.iceutica.com.
InnoCore Pharmaceuticals is a biopharmaceutical drug delivery company specialized in the development of complex parenteral sustained release formulations. By using our proprietary biodegradable polymers we can make microspheres, erodible gels and solid implants resulting in long acting and minimally invasive drug delivery products of small, medium sized (peptides) and large (proteins, antibodies) drug molecules. Learn more at www.innocorepharma.
Intract Pharma is a licensing and product development company offering proprietary, state-of-the-art oral drug delivery technologies and specialist gastrointestinal models for product innovation. Having successfully developed advanced formulations for small molecules, biopharmaceuticals and live biotherapeutic products, Intract can establish the optimal pathway from early pre-clinical screening through to clinical manufacture. Learn more at www.intractpharma.com.
LayerBio, Inc is an early-stage biotechnology company developing novel drug products based on its proprietary LayerForm™ delivery platform to address unmet needs for dermatology, wound care and surgical applications. Learn more about us at www.layerbio.com.
Leon-nanodrugs GmbH (Munich) is a nanotechnology-based drug development company focused on development of novel oral and parenteral pharmaceutical formulations and innovative drug combinations. Leon’s proprietary MJR® Technology platform provides a solution to overcome one of the key issues of most marketed therapeutics, poor water solubility, a pre-requisite for drug uptake into the body. Leon-nanodrugs has established CDMO partnerships in Europe and the US to enable access to key international markets. Leon’s first own product developed based on the MJR® Technology is planned to be submitted for Marketing Authorization in 2017. Leon-nanodrugs offers access to the next generation nano formulated drugs with added patient benefits and economical values for its partners and shareholders. Learn more at http://leon-nanodrugs.com.
Mitsubishi Gas Chemical does business in a wide range of fields, from basic chemicals to fine chemicals and functional materials. We have recently developed multilayer plastic vial and syringe for oxygen sensitive drugs like biologics. Although the product is made of plastic, it has achieved glass-like oxygen barrier. Learn more at http://www.mgc.co.jp/eng
Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries.
Nemera’s services and products cover several key delivery routes: Parenteral (auto-injectors, pens, safety devices & implanters), Ophthalmic (multi-dose, preservative-free eyedroppers), Nasal, buccal, auricular (pumps, valves and actuators for sprays), Inhalation (pMDIs, DPIs), Dermal and transdermal (airless & atmospheric dispensers). Nemera leverages decades of manufacturing and development experience in the device segment from full development of standard innovative products, such as the passive safety device for pre-filled syringes Safe’n’Sound®and the 2-step auto-injector Safelia®, to pure contract manufacturing, through customized solutions. Learn more at www.nemera.net.
NovaFlux, Inc, a Medical Technology Company, is well known and respected among the science and healthcare communities for our dedication and commitment to developing disruptive medical technologies and technology platforms leading to the creation of medical devices designed to solve some of the most complex & threatening medical problems in today’s global healthcare industry. Learn more about us at www.novaflux.com.
Oakwood is focused on the design, development, and aseptic manufacturing of sustained-release injectable microsphere products. We partner with companies in need of formulation development of their own products into sustained-release injectable form or contract manufacturing of their injectable drug. Oakwood has expertise in development of sustained-release injectable products using our patented microsphere technology. With our state of the art FDA approved cGMP aseptic manufacturing facility, Oakwood provides long term full-service supply and testing of aseptic injectable products to partners– from clinical trial material to commercial product. Learn more at www.oakwoodlabs.com
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development manufacturing and commercialization of innovative ocular therapies using its proprietary hydrogel platform. Our product pipeline candidates utilize the hydrogel technology to provide differentiated drug delivery solutions that are designed to greatly reduce the complexity and burden of current regimens. Learn more at www.ocutx.com.
Phillips-Medisize, a Molex company, is a technology-based provider of outsourced design and manufacturing services, with a significant business in the drug delivery space, as well as, single-use surgical medical devices, and therapeutic products. The company has expertise in high-speed manufacturing and automated inspection technologies. With early engagement in the design process, customers can expect accelerated speed to market for the products they chose to outsource. For more information, visit www.phillipsmedisize.com.
Phion Therapeutics Limited has developed a peptide nanoparticle for drug delivery that can deliver nucleic acids and other anionic compounds into tumors anywhere in the body at over a 30-fold the concentration relative to normal or healthy cells. Learn more at www.phiontx.co.uk
Phosphorex is a provider of customized drug delivery solutions, specializing in sustained release, targeted delivery and solubility enhancement. Our service offerings include drug encapsulation in microspheres and nanoparticles, solid dispersion, micronization and nanosizing, with aseptic processing and cGMP manufacturing capabilities. We support all stages of drug development from proof of concept to clinical trials. For more information, please visit www.phosphorex.com.
PolyPid Ltd. is a clinical stage biopharmaceutical company developing products based on its proprietary PLEX™ technology platform. PLEX™ is revolutionizing medicine by enabling localized, controlled and prolonged therapeutics. PLEX™ based products have demonstrated an excellent performance in clinical studies introducing best in class drugs for Surgical Site Infection management. Learn more at www.polypid.com.
Portal Instruments is developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for chronic diseases. Portal’s needle-free delivery technology is derived from research at MIT and enables the administration of high viscosity biologic drugs with significantly less discomfort and without the anxiety of handling needles. Using precise pressure technology, the injection is administered through the skin via a jet the size of a strand of hair, ensuring optimal comfort. Real time tracking and reporting sets a new standard for interactivity between the patient and care teams, monitoring adherence and potentially improving patient outcomes. For more information, visit www.portalinstruments.com.
pSivida is a specialty pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. The dedicated team of scientists at pSivida has developed three of the only four products approved by the FDA for the long-term, sustained-release delivery of drug to treat chronic back of the eye diseases. For more information, visit www.psivida.com.
Quantex is the innovative leader in single-use disposable pump technology. We have a catalogue of single-use pumps and also provide a design and development service for custom applications. Our engineers and designers are on hand to provide design expertise throughout the development programme and assistance into volume production. Quantex & Vernay have formed a strategic partnership to bring single-use precision pumps to the flow control market. In addition to performing a business development role Vernay can support the volume manufacture of Quantex pumps. Visit our websites to learn more about Quantex and Vernay.
Sensile Medical is a leading company in the area of micro-pumps and patch-pumps. These pumps are increasingly being used to enable Large-Volume Sub-Cutaneous delivery of modern biotech and pharmaceutical products for self-administration by patients. Sensile Medical solutions utilize electronically controlled rotary piston pump technology for highly accurate dosing regimens, enabling a broad range of drug delivery options. Founded in 2004, Sensile Medical is located in Haegendorf, Switzerland. Learn more at http://sensile-medical.com.
Serina Therapeutics, Inc has developed a patented drug delivery polymer technology based upon the water soluble polymer poly(2-oxazoline), or POZ™. We are developing a pipeline of proprietary and partnered programs applying this platform to cancer, pain, refractory epilepsy and movement disorders. Our most advanced program is SER-214, which has completed Phase I development in patients with Parkinson’s disease. SER-214 is a once-weekly subcutaneous injection that delivers the potent dopamine agonist rotigotine continuously, providing continuous dopaminergic stimulation. SER-214 will be advanced into Phase II development for both Parkinson’s disease and restless leg syndrome in 2017-2018. Two pipeline programs are scheduled to enter the clinic in 2018. SER-226/227 is a long-acting POZ-buprenorphine conjugate that is being advanced for post-operative pain with a target product profile of 3-7 days of analgesia. SER-228/229 is a POZ-cannabidiol conjugate that is being advanced as a once-weekly injection for refractory epilepsy and pain, as well as many other potential indications.
SMC Ltd. provides global contract manufacturing solutions of single-use devices for the pharmaceutical, medical and diagnostics industries. SMC provides full product services from initial concept through the final packaged device; including: program management, design and development, product manufacturing, clinical manufacturing, electronics integration, and global supply chain management. Visit www.smcltd.com
Founded in 1949, Stevanato Group is committed to create systems, processes and services that guarantee the integrity of parenteral medicines. It comprises two operational divisions dedicated to serve the pharmaceutical industry: Pharmaceutical Systems with Ompi specialized in glass primary packaging and Balda, focused on specialty plastics and delivery devices; Engineering Systems with Spami, Optrel, InnoScan and SVM, specialized in glass processing, inspection systems, assembly and packaging solutions. These two divisions enjoy a close, synchronous relationship, featuring daily exchanges which ensure that Stevanato Group has complete control over the entire production process. The Group also benefits from the SGLab activity that provides technical and analytical services on the potential interaction between drug and container. Visit www.stevanatogroup.com.
Suono Bio, Inc is developing breakthrough technology to enable ultra-rapid delivery of therapeutics and macromolecules across tissues without the need for reformulation or encapsulation. Preclinical studies have demonstrated the capacity to deliver small molecules, proteins, vaccines, and nucleic acids locally to specific tissues such as the gastrointestinal tract, as well as systemically. Learn more at www.suonobio.com.
Vaxess is developing next-generation immunotherapies and vaccines on the MIMIX sustained-dermal delivery platform. “Infection mimicry” via MIMIX boosts antibody and T-cell responses 10-100x, driving efficacy to previously unobtainable levels. This not only revives weakly immunogenic proteins, peptides, mRNA, etc, but also enables unique products like single-dose, self-administered vaccines. Learn more at http://vaxess.com.
West works side-by-side with its healthcare partners from concept to the patient, designing and manufacturing packaging, diagnostic and delivery systems that promote efficiency, reliability and safety. West leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge pharmaceutical product testing, development and packaging. Learn more at www.westpharma.com.
Windgap Medical is a specialty pharmaceutical company leveraging its miniature auto-injector platform to automate the rehydration and delivery of powdered drugs. Its small size and “two-steps-to-inject” operation reduces the time and complication with the administration of lyophilized and depot products. Through proprietary formulation enhancements we can speed up the rehydration for difficult to dissolve molecules. Learn more about us at www.windgapmedical.com.
Battelle combines medical device design and development, formulation expertise and human centric design to create innovative drug delivery systems that condense the development timeline and get our clients’ drugs to market faster. Battelle’s cross-disciplinary teams of experts mitigate risk and cut a clear path to regulatory approval for pharmaceutical companies looking to gain a competitive edge. Visit us at www.battelle.org.
BAUMANN – a global leading spring and stamping manufacturer with dedicated medical approach (ISO13485). We are your competent and reliable development partner in drug delivery device projects. Visit us at www.baumann-group.com.
DigiM Solution LLC pioneers in microstructure science. DigiM provides X-Ray and Focused Ion Beam Scanning Electron microscopy imaging service, artificial intelligence based image analytics, and image-based flow rate prediction for the design, evaluation, and optimization of drug and its release performance, medical devices and their long term quality, and any material samples when microstructure is important. Visit www.digimsolution.com for more information.
At Haselmeier we work in close cooperation with our pharmaceutical partners to create and deliver the safest and easiest to use injection devices for their patients. Our proven device platforms, world leading engineering and global manufacturing capabilities combined with an intense focus on patient needs provides our partners with a total product solution that helps improve patients’ lives. Visit us at http://haselmeier.com
Intertech Engineering specializes in disciplines centered on Medical Device design and development. Intertech supports clients through all phases of product development. Disciplines include Software Development, Hardware Development, Verification & Validation (incl. 820.70 & Part 11 Validations), Requirements Management, Risk Management and Software Regulatory Issues. Services offered include Assessments, Training, Consulting and Hands-on Engineering. Learn more at www.inea.com.
MANTA provides partners in the healthcare industry with award winning product development services. Our creative group specializes in early stage research / technology discovery to drive innovation and our ISO compliant process ensures product development excellence. Our team’s interactive culture and multi-disciplinary expertise in human factors, design and engineering provides the basis of forward thinking that leads to groundbreaking concepts and competitive advantage. Learn more at www.mantadesign.com.
Maxon motor is a long-time partner of leading medical technology companies worldwide and provides system solutions by combining DC motors, gears and controllers into high precision intelligent drives. With over 50 years of experience, high-tech innovations and superior product quality, maxon is the reliable partner in drive technology. Individual, customized drive solutions is our greatest strength. For more information, visit www.maxonmotorusa.com.
Mikron Corporation Denver is part of the Swiss based company Mikron Automation. With 40 years experience, 590 employees and 3000 installations worldwide, Mikron Automation continuously innovates to supply the best automated assembly and testing solutions for devices such as pen/auto-injectors, inhalers, syringes, e-devices and diagnostic kits. Learn more about us at www.mikron.com.
NN, Inc Precision Engineered Products Group is an engineered solutions company, focusing on medical and drug delivery devices. We provide components, complex assemblies and clean room packaging, specializing in metal stamping, injection molding and ISO Class VIII clean room assembly. Learn more at www.pep-corp.com.
Pharmaero ApS is a 50:50 joint venture between Scandinavian Health Limited (SHL) and Xellia Pharmaceuticals ApS . Pharmaero was founded in 2009 and is headed by Tomas Norling. The ADI®, Pharmaero’s key product, aims at optimizing treatment and addressing patient adherence by limiting some of the barriers in inhalation therapy. For more information, please visit www.pharmaero.com.
Polysciences, Inc provides custom manufacturing and development of biodegradable materials for drug discovery & delivery, medical devices, biotechnology, electronics and analytical chemistry industries, as well as high purity optical monomers, UV absorbing materials and specialty polymer additives to the ocular lens industry. To learn more, please visit www.polysciences.com or call (215) 343-6484 about your next project.
Renishaw is applying precision engineering technology to the challenges of medical research, diagnostics and surgical procedures. Our aim is to help leading clinicians to enhance the safety and cost-effectiveness of their procedures, improving patient outcomes through accurate delivery and development of implantable devices.
Our healthcare product portfolio includes medical devices, planning software and surgical robotic systems for use in procedures such as deep brain stimulation (DBS) for Parkinson’s disease, and Stereoelectroencephalography (SEEG) for the treatment of epilepsy. We also manufacture patient specific implants (PSI) for craniomaxillofacial (CMF) surgery, often required as a result of trauma or oncology therapy. Visit us at www.renishaw.com/en.
Our core competencies consist of design, development and production of customized electric motors, in large quantities. We are committed to develop mechatronic drive systems solutions that operate in challenging environments. Since 1936, our focus on innovation, best in class quality and service is our key to success for worldwide OEM. Sonceboz is ISO 13485 certified. www.sonceboz.com
SES provides value to our clients involved in producing innovative drug delivery systems. We use our extensive background in failure analysis, predictive methodology, risk assessment, and sustaining engineering to complete end-to-end development solutions for a wide range of drug delivery technologies. We support our clients solving their biggest development challenges. innovation.stress.com
Team Consulting is a multi-award winning medical device product development consultancy based in Cambridge, UK. Our specialists in human factors, engineering and industrial design work closely with our clients to develop complex drug delivery and medtech devices from concept to launch. Learn more at www.team-consulting.com
teamtechnik is an international market leader in innovative production technology, offering high-quality production systems and process technology for assembly and functional testing, high-performance and precision products in the automotive, medtech and solar sector. Learn more at www.teamtechnik.com
We develop alliances with pharmaceutical companies on a global scale, using Terumo technology to develop, manufacture and supply carefully crafted solutions to their injectable drug delivery challenges. We pride ourselves on offering a full portfolio of products and services for the pharmaceutical industry, backed by unrivaled scientific expertise and know-how. By anticipating new trends and maintaining a constant dialogue, we provide a first class customer experience. Learn more at www.terumo-ps.com.
URSATEC stands for innovative developments in preservative-free pharmaceutical, medical device and cosmetic products such as oral and nasal sprays. Safe protection against contamination by microorganisms, even after the opening of a package, is guaranteed by the dual microbiological protection of the patented dosing systems 3K® and COMFORT®. Learn more about us at www.ursatec.com/en.
2017 Soapbox Sponsors
BioHealthWays is a biopharmaceutical company developing specialty drug delivery technology to sustain the release of biologics. We are focused on fighting preventable blindness. To learn more, visit www.biohealthway.com.
Pendant Biosciences is an advanced materials company developing innovative surface coating and drug delivery technologies using a unique, polymer-based platform. The company is initially focused on applications within the orthopedic market, and its lead product candidate is a surface modification intended to reduce the risk of infection associated with certain orthopedic implants. The platform also serves as a product engine with broad utility in multiple therapeutic areas.
Sonoran Biosciences is an early stage pharmaceutical company that has developed SB Gel, a viscous and resorb-able carrier that provides multi-day sustained drug release. Sonoran’s first product, SBG002, is being developed to enable one-stage treatment of prosthetic joint infection. Sonoran is currently funded by an NIH Phase 2 SBIR grant. Learn more at www.sonoranbiosciences.com.
Subcuject is a start up company focused on providing a flexible, reliable, environmentally friendly, wearable injection device for the fast growing market of biologics at a significantly lower cost than other devices. The device utilizes next generation osmotic technology.